For clinics, med spas and telehealth. And everyone in peptides and longevity.

Monday, Nov. 2, 2026

HHS 503A peptide guide

HHS named six peptides it says it won't act against when a 503A pharmacy compounds them under ten conditions. HHS calls it an interim policy and says it "is not binding on HHS or the public."

This page is for ODR subscribers

Enter your email and we'll send you a code. The code opens every tool and guide in this browser. If you're new, this also subscribes you to Optimized Daily Report, sent every weekday at 6:30 a.m. ET. If you already subscribe, use the same email.